Author:
Schor Jonathan S,Montalvo Isabelle Gonzalez,Spratt Perry W E,Brakaj Rea J,Stansil Jasmine A,Bender Kevin J,Nelson Alexandra B
Abstract
AbstractSubthalamic nucleus deep brain stimulation (STN DBS) relieves many motor symptoms of Parkinson’s Disease (PD), but its underlying therapeutic mechanisms remain unclear. Since its advent, three major theories have been proposed: (1) DBS inhibits the STN and basal ganglia output; (2) DBS antidromically activates motor cortex; and (3) DBS disrupts firing dynamics within the STN. Previously, stimulation-related electrical artifacts limited mechanistic investigations using electrophysiology. We used electrical artifact-free calcium imaging to investigate activity in basal ganglia nuclei during STN DBS in parkinsonian mice. To test whether the observed changes in activity were sufficient to relieve motor symptoms, we then combined electrophysiological recording with targeted optical DBS protocols. Our findings suggest that STN DBS exerts its therapeutic effect through the disruption of STN dynamics, rather than inhibition or antidromic activation. These results provide insight into optimizing PD treatments and establish an approach for investigating DBS in other neuropsychiatric conditions.
Publisher
Cold Spring Harbor Laboratory
Reference63 articles.
1. Subthalamotomy in Treatment of Parkinsonian Tremor;J. Neurosurg,1963
2. Reversal of Experimental Parkinsonism by Lesions of the Subthalamic Nucleus
3. Biomarkers for closed-loop deep brain stimulation in Parkinson disease and beyond
4. Neurotoxin-based models of Parkinson’s disease. Neuroscience;Neuroscience Disease Models,2012
5. Campos, F.L. , Carvalho, M.M. , Cristovão, A.C. , Je, G. , Baltazar, G. , Salgado, A.J. , Kim, Y.-S. , Sousa, N. , 2013. Rodent models of Parkinson’s disease: beyond the motor symptomatology. Front. Behav. Neurosci. 7. https://doi.org/10.3389/fnbeh.2013.00175